Publications

Found 10 results
Filters: Author is Z.T. Wang  [Clear All Filters]
2012
Y. Zhang, Wang, Z. T., and Zhong, J., Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in Asians, vol. 11, pp. 2328-2337, 2012.
Chen D, Chi Y, Yu Q, Wang S, et al. (2007). Interaction of polymorphisms of NQO1 and environmental risk factors in gastric cancer. Acta Univ. Medicinalis Anhui 42: 405-408.   Chen DJ, Ding R, Cao W and Ye DQ (2011). Interaction between polymorphisms in NQO1(C609T) and XRCC1(G28152A) and their correlation with smoking on gastric cancer. Zhonghua Liu Xing Bing Xue Za Zhi 32: 5-8. PMid:21518531   Cohn LD and Becker BJ (2003). How meta-analysis increases statistical power. Psychol. Methods 8: 243-253. http://dx.doi.org/10.1037/1082-989X.8.3.243 PMid:14596489   El-Rifai W, Frierson HF Jr, Moskaluk CA, Harper JC, et al. (2001). Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology 121: 592-598. http://dx.doi.org/10.1053/gast.2001.27215 PMid:11522743   Forman D, Newell DG, Fullerton F, Yarnell JW, et al. (1991). Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302: 1302-1305. http://dx.doi.org/10.1136/bmj.302.6788.1302 PMid:2059685 PMCid:1670011   Gammon MD, Schoenberg JB, Ahsan H, Risch HA, et al. (1997). Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst. 89: 1277-1284. http://dx.doi.org/10.1093/jnci/89.17.1277 PMid:9293918   Goto Y, Hamajima N, Honda H, Matsuo K, et al. (2005). Association between Helicobacter pylori seropositivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism observed in outpatients and health checkup examinees. Gastric. Cancer 8: 12-17. http://dx.doi.org/10.1007/s10120-004-0308-1 PMid:15747169   Hamajima N, Matsuo K, Iwata H, Shinoda M, et al. (2002). NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int. J. Clin. Oncol. 7: 103-108. PMid:12018106   Hemminki K, Lorenzo BJ and Forsti A (2006). The balance between heritable and environmental aetiology of human disease. Nat. Rev. Genet. 7: 958-965. http://dx.doi.org/10.1038/nrg2009 PMid:17139327   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919   Higgins JP, Thompson SG, Deeks JJ and Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327: 557-560. http://dx.doi.org/10.1136/bmj.327.7414.557 PMid:12958120 PMCid:192859   Iskander K, Gaikwad A, Paquet M, Long DJ, et al. (2005). Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. Cancer Res. 65: 2054-2058. http://dx.doi.org/10.1158/0008-5472.CAN-04-3157 PMid:15781611   Kuehl BL, Paterson JW, Peacock JW, Paterson MC, et al. (1995). Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br. J. Cancer 72: 555-561. http://dx.doi.org/10.1038/bjc.1995.373 PMid:7669561 PMCid:2033894   Long DJ, Waikel RL, Wang XJ, Perlaky L, et al. (2000). NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res. 60: 5913-5915. PMid:11085502   Long N, Moore MA, Chen W, Gao CM, et al. (2010). Cancer epidemiology and control in north-East Asia - past, present and future. Asian Pac. J. Cancer Prev. (Suppl 11) 2: 107-148.   Malik MA, Zargar SA and Mittal B (2011). Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley. DNA Cell Biol. 30: 297-303. http://dx.doi.org/10.1089/dna.2010.1115 PMid:21294640   Parkin DM, Bray F, Ferlay J and Pisani P (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108. http://dx.doi.org/10.3322/canjclin.55.2.74 PMid:15761078   Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, et al. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325: 1127-1131. http://dx.doi.org/10.1056/NEJM199110173251603 PMid:1891020   Rauth AM, Goldberg Z and Misra V (1997). DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncol. Res. 9: 339-349. PMid:9406240   Ren JJ, Ouyang XH and Su XL (2006). NAD(P)H: quinone oxidoreductase gene polymorphism association with gastric carcinoma. Chin. J. Cancer Prev. Treat. 13: 1686-1688.   Ruano-Ravina A, Perez-Rios M and Barros-Dios JM (2008). Population-based versus hospital-based controls: are they comparable? Gac. Sanit. 22: 609-613. http://dx.doi.org/10.1016/S0213-9111(08)75363-9   Salanti G, Sanderson S and Higgins JP (2005). Obstacles and opportunities in meta-analysis of genetic association studies. Genet. Med. 7: 13-20. http://dx.doi.org/10.1097/01.GIM.0000151839.12032.1A PMid:15654223   Sarbia M, Bitzer M, Siegel D, Ross D, et al. (2003). Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int. J. Cancer 107: 381- 386. http://dx.doi.org/10.1002/ijc.11430 PMid:14506737   Suerbaum S and Michetti P (2002). Helicobacter pylori infection. N. Engl. J. Med. 347: 1175-1186. http://dx.doi.org/10.1056/NEJMra020542 PMid:12374879   Tajima Y, Yamazaki K, Makino R, Nishino N, et al. (2007). Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br. J. Cancer 96: 631-638. http://dx.doi.org/10.1038/sj.bjc.6603583 PMid:17262083 PMCid:2360051   Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, et al. (1999). Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br. J. Surg. 86: 529-535. http://dx.doi.org/10.1046/j.1365-2168.1999.01082.x PMid:10215831   Xue L, Zhang X, Li Y, Yang H, et al. (2011). Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach. Hum. Pathol. 42: 594-601. http://dx.doi.org/10.1016/j.humpath.2010.06.015 PMid:21146193   Yoshida T, Ono H, Kuchiba A, Saeki N, et al. (2010). Genome-wide germline analyses on cancer susceptibility and GeMDBJ database: gastric cancer as an example. Cancer Sci. 101: 1582-1589. http://dx.doi.org/10.1111/j.1349-7006.2010.01590.x PMid:20507324   Yu K, Zhang J, Zhang J, Dou C, et al. (2010). Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur. J. Hum. Genet. 18: 370-378. http://dx.doi.org/10.1038/ejhg.2009.131 PMid:19826453 PMCid:2987221   Zhang JH, Li Y, Wang R, Geddert H, et al. (2003). NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J. Gastroenterol. 9: 1390-1393. PMid:12854127   Zhu F, Loh M, Hill J, Lee S, et al. (2009). Genetic factors associated with intestinal metaplasia in a high risk Singapore- Chinese population: a cohort study. BMC Gastroenterol. 9: 76. http://dx.doi.org/10.1186/1471-230X-9-76 PMid:19822020 PMCid:2766386